Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin P Dunn

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Cold Spring Harbor Molecular Case Studies|February 15, 2018
Resistance-promoting effects of ependymoma treatment revealed through genomic analysis of multiple recurrences in a single patientChristopher A Miller, Sonika Dahiya, Tiandao Li, et al.
Brain Tumor Pathology|March 11, 2016
High incidence of TERT mutation in brain tumor cell linesTanner M Johanns, Yujie Fu, Dale K Kobayashi, et al.
Journal of Neuro-Oncology|December 9, 2025
Immunotherapy and targeted therapy for high grade gliomas: current and future directionsBrian Hsueh, Samuel J Steuart, Angel O Odukoya, et al.
Scientific Reports|April 28, 2018
Focused Ultrasound-enabled Brain Tumor Liquid BiopsyLifei Zhu, Galen Cheng, Dezhuang Ye, et al.
Cell Communication and Signaling : CCS|September 20, 2017
Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signalingYu Mei, Ziming Du, Changchen Hu, et al.
CA: a Cancer Journal for Clinicians|March 26, 2026
Integrating multimodal management and molecular profiling in a patient with BRAF V600E-positive melanoma and brain metastasesDavid Gritsch, Riley M Fadden, Maura K Mahar, et al.
Immunologic Research|August 18, 2005
Interferon-gamma and cancer immunoeditingGavin P Dunn, Hiroaki Ikeda, Allen T Bruce, et al.
Pituitary|January 25, 2021
Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expressionYu Mei, Wenya Linda Bi, James Agolia, et al.
Neuro-Oncology Practice|July 15, 2024
Burnout and career satisfaction in young neuro-oncology investigators: Results of the Society for Neuro-Oncology Young Investigator SurveyGilbert Youssef, Alvina Acquaye-Mallory, Elizabeth Vera, et al.
Cancer Research|November 17, 2011
ERK1/2 regulation of CD44 modulates oral cancer aggressivenessNancy P Judd, Ashley E Winkler, Oihana Murillo-Sauca, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Cold Spring Harbor Molecular Case Studies|February 15, 2018
Resistance-promoting effects of ependymoma treatment revealed through genomic analysis of multiple recurrences in a single patientChristopher A Miller, Sonika Dahiya, Tiandao Li, et al.
Brain Tumor Pathology|March 11, 2016
High incidence of TERT mutation in brain tumor cell linesTanner M Johanns, Yujie Fu, Dale K Kobayashi, et al.
Journal of Neuro-Oncology|December 9, 2025
Immunotherapy and targeted therapy for high grade gliomas: current and future directionsBrian Hsueh, Samuel J Steuart, Angel O Odukoya, et al.
Scientific Reports|April 28, 2018
Focused Ultrasound-enabled Brain Tumor Liquid BiopsyLifei Zhu, Galen Cheng, Dezhuang Ye, et al.
Cell Communication and Signaling : CCS|September 20, 2017
Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signalingYu Mei, Ziming Du, Changchen Hu, et al.
CA: a Cancer Journal for Clinicians|March 26, 2026
Integrating multimodal management and molecular profiling in a patient with BRAF V600E-positive melanoma and brain metastasesDavid Gritsch, Riley M Fadden, Maura K Mahar, et al.
Immunologic Research|August 18, 2005
Interferon-gamma and cancer immunoeditingGavin P Dunn, Hiroaki Ikeda, Allen T Bruce, et al.
Pituitary|January 25, 2021
Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expressionYu Mei, Wenya Linda Bi, James Agolia, et al.
Neuro-Oncology Practice|July 15, 2024
Burnout and career satisfaction in young neuro-oncology investigators: Results of the Society for Neuro-Oncology Young Investigator SurveyGilbert Youssef, Alvina Acquaye-Mallory, Elizabeth Vera, et al.
Cancer Research|November 17, 2011
ERK1/2 regulation of CD44 modulates oral cancer aggressivenessNancy P Judd, Ashley E Winkler, Oihana Murillo-Sauca, et al.
Pageof 15